GRIN2A: one gene, many phenotypes

Area of Science:

• Neurogenetics
• Psychiatric Genetics
• Epilepsy Research

Background:

• The GRIN2A gene encodes a subunit of the N-methyl-d-aspartate (NMDA) receptor.
• GRIN2A variants are associated with epilepsy, language impairment, and schizophrenia.
• The precise relationship between these conditions and GRIN2A in individuals is not fully understood.

Purpose of the Study:

• To investigate the relationship between GRIN2A variants and associated neurodevelopmental and psychiatric conditions.
• To explore how study design influences the observed gene-disease associations for GRIN2A.

Main Methods:

• Re-contacting and re-evaluating a cohort of GRIN2A carriers.
• Analyzing genetic variants, specifically loss-of-function variants in GRIN2A.
• Comparing findings from initial ascertainment with subsequent re-evaluation.

Main Results:

• Loss-of-function variants in GRIN2A are associated with psychiatric risk.
• This psychiatric risk was not identified during the initial assessment of the cohort.
• Study design significantly impacts the detection of gene-disease relationships.

Conclusions:

• Re-evaluation of GRIN2A carriers reveals previously uncaptured psychiatric risks.
• The study highlights the critical role of study design in understanding complex gene-disease associations.
• Findings underscore the pleiotropic effects of GRIN2A variants across neurological and psychiatric domains.